Search

everythinglearnresearchcommunity

for

Search:↓

Some children are born with unusually short, fine hair because their hair growth phase is short, but this often gets better by itself during puberty.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

A woman experienced rapid hair loss after taking albendazole, but it started to improve when she stopped the medication.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Trichobiolight effectively treats hair loss with 82.5% success.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Amitriptyline can cause temporary hair loss, which stops after discontinuing the drug.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

Researchers developed a new method using methylene blue staining to more accurately identify the growth stage of human hair follicles.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

Minoxidil helps hair growth by activating the β-catenin pathway.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Modified pep7, named EPM peptide, effectively promotes hair growth at low concentrations and works well with minoxidil.

Right hand finger ratio may predict male hair loss.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

GV-350 improves hair growth and quality of life in iron-deficient women without side effects.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

A patient's hair loss after a browlift surgery improved on its own over 8 months.